SLC29A1 and neoplasm: Therefore, drug resistance associated with deficiencies in the expression of hENT1 confers lower gemcitabine toxicity in tumor cells by blocking the cellular transport of gemcitabine (Chung et al., 2012[9]; Tao et al., 2012[41]).